PharmaShots | Incisive News in 3 Shots

Subscribe Now

Juvisé Pharmaceuticals

Juvisé Pharmaceuticals Reports the Acquisition of Actelion’s Ponvory (ponesimod) for the Treatment of Multiple Sclerosis (MS)

Juvisé Pharmaceuticals Reports the Acquisition of Actelion’s Ponvory (ponesimod) for the Treatment of Multiple Sclerosis (MS)

March 27, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us